Spotlight

Healthcare professionals and public health campaigns are significant sources of COPD-related stigma and can reduce patients’ motivation to stop smoking.

A recent article in Primary Care Companion for CNS Disorders discusses the risk factors, monitoring strategies, and treatment options for tardive dyskinesia.

A recent article reported on the risk factors, monitoring strategies, and treatment options for tardive dyskinesia to help clinicians improve patient outcomes.

Evaluating risk factors in COPD requires a multifaceted approach, from reassessing the GOLD criteria to understanding the influence of environmental factors such as weather on mortality rates.

It is important for clinicians to understand the causes and symptoms of tardive dyskinesia to avoid common misdiagnoses and ensure effective management.

In 2024, melanoma—both metastatic and non-metastatic—is estimated to result in 100,640 new cases and 8,290 deaths in the United States.

Researchers explored risk factors for frailty in patients with COPD, emphasizing the need for early identification and intervention to improve outcomes.

A short educational activity on tardive dyskinesia significantly improved clinicians’ confidence in managing and choosing therapies.

Extreme temperatures increase COPD hospitalizations and deaths, with cold having a greater impact.

Valbenazine and vitamin E are the most effective treatments for tardive dyskinesia, with valbenazine showing the strongest effect size in recent studies.

GLI thresholds reduce COPD overdiagnosis in older smokers vs. GOLD, aligning severity with clinical signs and reducing unnecessary treatments.

Loneliness appears to be a more important risk factor for symptom exacerbations and acute health service use among adults with COPD than asthma.

A recent cohort study assessed the accuracy of the GOLD exacerbation history categories in estimating moderate and severe ECOPD and all-cause mortality in patients with COPD.

Immunotherapy (IO) has transformed the way certain cancers can be treated over the past decade—positioning it as a critical pillar in cancer therapy.

Do you remember the recent COPD research? Test your knowledge now and see how you rank!

A 69-year old patient from Southeast Asia presents with a 10-year history of cough and progressive dyspnea. The patient denies tobacco use or exposure.